Your browser doesn't support javascript.
loading
Epsin-mediated degradation of IP3R1 fuels atherosclerosis.
Dong, Yunzhou; Lee, Yang; Cui, Kui; He, Ming; Wang, Beibei; Bhattacharjee, Sudarshan; Zhu, Bo; Yago, Tadayuki; Zhang, Kun; Deng, Lin; Ouyang, Kunfu; Wen, Aiyun; Cowan, Douglas B; Song, Kai; Yu, Lili; Brophy, Megan L; Liu, Xiaolei; Wylie-Sears, Jill; Wu, Hao; Wong, Scott; Cui, Guanglin; Kawashima, Yusuke; Matsumoto, Hiroyuki; Kodera, Yoshio; Wojcikiewicz, Richard J H; Srivastava, Sanjay; Bischoff, Joyce; Wang, Da-Zhi; Ley, Klaus; Chen, Hong.
Afiliação
  • Dong Y; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Lee Y; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Cui K; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • He M; Department of Medicine, University of California, San Diego, San Diego, CA, 92093, USA.
  • Wang B; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Bhattacharjee S; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Zhu B; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Yago T; Cardiovascular Biology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA.
  • Zhang K; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Deng L; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA.
  • Ouyang K; Department of Medicine, University of California, San Diego, San Diego, CA, 92093, USA.
  • Wen A; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Cowan DB; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Song K; Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Yu L; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Brophy ML; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Liu X; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Wylie-Sears J; Center for Vascular and Developmental Biology, Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Chicago, IL, 60611, USA.
  • Wu H; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Wong S; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Cui G; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Kawashima Y; Department of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.
  • Matsumoto H; Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
  • Kodera Y; Center for Disease Proteomics, Kitasato University School of Science, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0373, Japan.
  • Wojcikiewicz RJH; Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
  • Srivastava S; Center for Disease Proteomics, Kitasato University School of Science, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0373, Japan.
  • Bischoff J; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
  • Wang DZ; Department of Medicine, Division of Cardiovascular Medicine, University of Louisville School of Medicine, Louisville, KY, 40202, USA.
  • Ley K; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Chen H; Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Nat Commun ; 11(1): 3984, 2020 08 07.
Article em En | MEDLINE | ID: mdl-32770009
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Adaptadoras de Transporte Vesicular / Aterosclerose / Receptores de Inositol 1,4,5-Trifosfato / Proteólise Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Adaptadoras de Transporte Vesicular / Aterosclerose / Receptores de Inositol 1,4,5-Trifosfato / Proteólise Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos